High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts (original) (raw)

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study

Olga Endrich

Authorea (Authorea), 2021

View PDFchevron_right

SARS-CoV-2 infection among patients with systemic autoimmune diseases

Irene Mattioli

Autoimmunity Reviews, 2020

View PDFchevron_right

Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina—One year later

Daria Ler

PLOS ONE, 2022

View PDFchevron_right

A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies

Thu Kim

bioRxiv (Cold Spring Harbor Laboratory), 2024

View PDFchevron_right

Clinical characteristics of 51,815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings: Priority populations for vaccination

Ehab Hamed

Journal of Infection, 2021

View PDFchevron_right

Role of Anti-SARS-CoV-2 antibodies in different cohorts: Can they provide clues for appropriate patient triaging?

Amin Mohammad

bioRxiv (Cold Spring Harbor Laboratory), 2020

View PDFchevron_right

SARS-CoV-2 Antibody Testing in Healthcare Workers: a comparison of the clinical performance of three commercially available antibody assays

Colm Bergin

medRxiv (Cold Spring Harbor Laboratory), 2021

View PDFchevron_right

Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman

Elias SAID

Journal of Infection and Public Health, 2021

View PDFchevron_right

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand

Susan Jack

Clinical & Translational Immunology

View PDFchevron_right

Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure

Claire Klaisner

JCI Insight, 2021

View PDFchevron_right

SARS-CoV-2 Antibodies Seroconversion in Healthcare Workers at a Tertiary Cancer Center

Hani Al-Najjar

2023

View PDFchevron_right

Diagnostics for SARS-CoV-2 infections

NEHA BAJWA

Nature Materials, 2021

View PDFchevron_right

Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression

biby edwin

Indian Journal of Clinical Biochemistry

View PDFchevron_right

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Rachel Bousfield

Cell Reports Medicine, 2020

View PDFchevron_right

Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2

Sylvia Boesch

European Journal of Neurology, 2020

View PDFchevron_right

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

Naveenchandra Suryadevara

Cell Reports

View PDFchevron_right

Community-Based Testing for SARS-CoV-2 — Chicago, Illinois, May–November 2020

Peter Ruestow

MMWR. Morbidity and Mortality Weekly Report, 2021

View PDFchevron_right

High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Percy Mayta-Tristan

International Journal of Infectious Diseases, 2021

View PDFchevron_right

Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection

Nicolas Vuilleumier

medRxiv (Cold Spring Harbor Laboratory), 2022

View PDFchevron_right

Interaction between SARS-CoV-2 and human organism

Valentin Cebotarescu

2020

View PDFchevron_right

Advancement of SARS-CoV-2 infection in children

fuyong jiao

Pediatria polska, 2021

View PDFchevron_right

Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination

Flavia Salles

SSRN Electronic Journal, 2021

View PDFchevron_right

Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays

Gokhan Metan

Japanese Journal of Infectious Diseases

View PDFchevron_right

Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies

Max Lau

Epidemiology, 2021

View PDFchevron_right

Performance of a rapid antigen test for SARS-CoV-2 in Kenya

Fredrick Oluoch

Diagnostic Microbiology and Infectious Disease, 2021

View PDFchevron_right